HSCT may lower leukemia risk in ELANE neutropenia: a before–after study from the French Severe Congenital Neutropenia Registry

ELANE neutropenia is associated with myelodysplasia and acute leukemia (MDS–AL), and severe infections. Because the MDS–AL risk has also been shown to be associated with exposure to GCSF, since 2005, in France, patients receiving high daily GCSF doses (>15 μg/kg/day) are eligible for HSCT, in add...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Bone Marrow Transplant
Main Authors: Rotulo, Gioacchino Andrea, Beaupain, Blandine, Rialland, Fanny, Paillard, Catherine, Nachit, Ouahiba, Galambrun, Claire, Gandemer, Virginie, Bertrand, Yves, Neven, Benedicte, Dore, Eric, Moshous, Despina, Filhon, Bruno, Aladjdi, Nathalie, Sicre de Fontbrune, Flore, de la Tour, Regis Peffault, Ouachee, Marie, Bellanne-Chantelot, Christine, Dalle, Jean-Hugues, Donadieu, Jean
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7091645/
https://ncbi.nlm.nih.gov/pubmed/31992846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-020-0800-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados